Tamoxifen elevates transforming growth factor–β and suppresses diet–induced formation of lipid lesions in mouse aorta

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature Medicine

• Publication date

  1995-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/NM1095-1067PMID 7489365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis

  1995cited by this paper
• A PIVOTAL ROLE FOR TGF‐β* IN ATHEROGENESIS?

  1995cited by this paper
• A pivotal role for TGF-beta in atherogenesis?

  1995cited by this paper
• Active and acid-activatable TGF-beta in human sera, platelets and plasma.

  1995cited by this paper
• Active and acid-activatable TGF-β in human sera, platelets and plasma

  1995cited by this paper
• Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men.

  1994cited by this paper
• Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.

  1994cited by this paper
• Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice

  1994cited by this paper
• Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women.

  1994cited by this paper
• High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

  1994cited by this paper
• Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

  1994cited by this paper
• Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice.

  1994cited by this paper
• Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

  1994cited by this paper
• Risk of endometrial cancer after tamoxifen treatment of breast cancer.

  1994cited by this paper
• Proliferation of human smooth muscle cells promoted by lipoprotein(a).

  1993cited by this paper
• Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.

  1993cited by this paper
• Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.

  1993cited by this paper
• Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta.

  1993cited by this paper
• Adult human aortic smooth muscle cells in culture produce active TGF-beta.

  1993cited by this paper
• Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells.

  1993cited by this paper
• Induction of Transforming Growth Factor β1 in Human Breast Cancer in Vivo following Tamoxifen Treatment

  1992cited by this paper
• Effects of Calorie Restriction on Immunologic Functions and Development of Autoimmune Disease in NZB Mice

  1992cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

  1992cited by this paper
• Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

  1991cited by this paper
• Pathology of atherosclerosis in cholesterol-fed, susceptible mice.

  1991cited by this paper
• Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.

  1991cited by this paper
• Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR).

  1991cited by this paper
• The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.

  1991cited by this paper
• Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

  1990cited by this paper
• Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity.

  1990cited by this paper
• Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

  1990cited by this paper
• Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors.

  1990cited by this paper
• Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice.

  1990cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper
• Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levels

  1988cited by this paper
• Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain.

  1988cited by this paper
• Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H.

  1987cited by this paper
• Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice.

  1987cited by this paper
• Triphenylethylenes: a new class of protein kinase C inhibitors.

  1986cited by this paper
• Platelet function in a case with abetalipoproteinemia.

  1985cited by this paper
• Effect of 3-methylcholanthrene on the development of aortic lesions in mice.

  1985cited by this paper
• Variation in susceptibility to atherosclerosis among inbred strains of mice.

  1985cited by this paper
• The pharmacology and clinical uses of tamoxifen.

  1984cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper

• TGF-β-Based Therapies for Treating Ocular Surface Disorders

  2024cites this paper
• The beneficial effects of tamoxifen on arteries: a key player for cardiovascular health of breast cancer patient.

  2023cites this paper
• Transcription factor GATA6 promotes migration of human coronary artery smooth muscle cells in vitro

  2022cites this paper
• Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism

  2022influential citation
• Plaque Collagen Synthesis and Calcification: Working Together to Protect Against Instability and Rupture

  2021cites this paper
• Role of MiR-148b in angiogenesis and endothelial cell plasticity

  2019cites this paper
• Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway

  2017cites this paper
• Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse.

  2017cites this paper
• Efecto del tamoxifeno, raloxifeno y toremifeno sobre la actividad y expresión del receptor de LDL en linfocitos primarios humanos

  2016cites this paper
• Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen

  2016cites this paper
• Impact of age and sex on the development of atherosclerosis and expression of the related genes in apoE deficient mice.

  2016cites this paper
• Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials

  2016cites this paper
• Inhibition of macrophage CD 36 expression and cellular oxLDL accumulation by tamoxifen — A PPARγ dependent mechanism

  2016cites this paper
• Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport

  2016cites this paper
• Tamoxifen induces the development of hernia in mice by activating MMP-2 and MMP-13 expression.

  2015cites this paper
• Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways.

  2013cites this paper
• Tamoxifen elicits atheroprotection through estrogen receptor α AF-1 but does not accelerate reendothelialization.

  2013cites this paper
• Statins Induce the Accumulation of Regulatory T Cells in Atherosclerotic Plaque

  2012cites this paper
• Matrix metalloproteinase-8 as a diagnostic tool for the inflammatory and malignant diseases

  2011cites this paper
• A tale of two plaques: convergent mechanisms of T‐cell‐mediated inflammation in psoriasis and atherosclerosis

  2011cites this paper
• Induction of macrophage scavenger receptor type BI expression by tamoxifen and 4-hydroxytamoxifen.

  2011cites this paper
• Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake

  2011cites this paper
• Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta.

  2010cites this paper
• Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects

  2010cites this paper
• Treatment with selective estrogen receptor modulators regulates myelin specific T‐cells and suppresses experimental autoimmune encephalomyelitis

  2009influential citation
• The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies.

  2009cites this paper
• A meprin inhibitor suppresses atherosclerotic plaque formation in ApoE-/- mice.

  2009cites this paper
• Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice.

  2009cites this paper
• Involvement of osteopontin as a core protein in cholesterol gallstone formation.

  2009cites this paper
• TGF-beta-зависимый патогенез синдрома марфана и родственных наследственных нарушений соединительной ткани

  2009cites this paper
• Atherosclerosis--an immune disease: The Anitschkov Lecture 2007.

  2009cites this paper
• Major histocompatibility complex and coronary artery disease: Special emphasis on Chlamydia pneumoniae, and periodontitis

  2008cites this paper
• Role of transforming growth factor-beta superfamily signaling pathways in human disease.

  2008cites this paper
• TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.

  2008cites this paper
• TGF-β and atherosclerosis in man

  2007cites this paper
• Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.

  2007cites this paper
• Transforming Growth Factor Activity Is a Key Determinant for the Effect of Estradiol on Fatty Streak Deposit in Hypercholesterolemic Mice

  2007cites this paper
• Over-expression of IGF-related peptides in stenoses of native arteriovenous fistulas in hemodialysis patients.

  2007cites this paper
• Inhibition of the TGF-beta signaling pathway in tumor cells.

  2007cites this paper
• Inhibition of the TGF-β Signaling Pathway in Tumor Cells

  2007cites this paper
• TGF-beta and atherosclerosis in man.

  2007cites this paper
• TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors.

  2006cites this paper
• Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients.

  2006cites this paper
• The Role of Smad3-Dependent TGF-β Signal in Vascular Response to Injury

  2006cites this paper
• Inflammation and atherosclerosis.

  2006cites this paper
• The role of transforming growth factor-β in atherosclerosis

  2006cites this paper
• Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.

  2006cites this paper
• Frequency of Polymorphisms of Signal Peptide of TGF‐β1 and −1082G/A SNP at the Promoter Region of Il‐10 Gene in Patients with Carotid Stenosis

  2006cites this paper
• The role of transforming growth factor-beta in atherosclerosis.

  2006cites this paper
• The role of Smad3-dependent TGF-beta signal in vascular response to injury.

  2006cites this paper
• The role of transforming growth factor h 1 in the vascular system

  2005cites this paper
• Gender-based differences in bleomycin-induced pulmonary fibrosis.

  2005cites this paper
• Tamoxifen for the Prevention of Myocardial Infarction in Humans: Preclinical and Early Clinical Evidence

  2005cites this paper
• Transforming Growth Factor J Is Essential for Spindle Cell Conversion of Mouse Skin Carcinoma in Vivo : Implications for Tumor Invasion 1

  2005cites this paper
• Inhibitory control of TGF‐β1 on the activation of Rap1, CD11b, and transendothelial migration of leukocytes

  2005cites this paper
• The role of transforming growth factor beta1 in the vascular system.

  2005cites this paper
• Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis.

  2005cites this paper
• Targeted Disruption of TGF-&bgr;–Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury

  2005cites this paper
• Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM).

  2005cites this paper
• Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens.

  2004cites this paper
• State in Apolipoprotein E-Deficient Mice Resulting in a Systemic Proinflammatory Apoptotic Bodies In Vitro and In Vivo, Apolipoprotein E Modulates Clearance of

  2004cites this paper
• Transforming Growth Factor-β1 Gene Polymorphisms and Bone Turnover, Bone Mineral Density and Fracture Risk in Southern Chinese Women

  2004cites this paper
• Atherosclerosis and the immune system

  2004cites this paper
• Tamoxifen Is a Potent Inhibitor of Cholesterol Esterification and Prevents the Formation of Foam Cells

  2004influential citation
• Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice1

  2004cites this paper
• Detrimental and protective roles of adaptive immunity in atherosclerosis

  2004cites this paper
• Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women.

  2004cites this paper
• Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.

  2003cites this paper
• CD4+ T cells in atherosclerosis.

  2003cites this paper
• TGF beta/Smad signaling system and its pathologic correlates.

  2003cites this paper
• Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.

  2003cites this paper
• Cartilaginous metaplasia and calcification in aortic allograft is associated with transforming growth factor beta 1 expression.

  2003cites this paper
• Genetic Polymorphisms in Cytokine and Adhesion Molecule Genes in Coronary Artery Disease

  2003cites this paper
• [Influence of different pharmacological agents in the ex vivo proliferation of mesothelial cells obtained from the peritoneal effluent of patients treated with peritoneal dialysis].

  2003cites this paper
• TGFβ/Smad signaling system and its pathologic correlates

  2003cites this paper
• Cocoa Flavonols and Procyanidins Promote Transforming Growth Factor-β1 Homeostasis in Peripheral Blood Mononuclear Cells1

  2003cites this paper
• Disruption of TGF-β signaling in T cells accelerates atherosclerosis

  2003cites this paper
• Smad2 Mediates Transforming Growth Factor-&bgr; Induction of Endothelial Nitric Oxide Synthase Expression

  2002cites this paper
• Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects.

  2002cites this paper
• SERMs Effects on Cardiovascular Risk Factors and Disease

  2002cites this paper
• Changes in proinflammatory cytokine activity after menopause.

  2002cites this paper
• Estrogen Receptors (cid:1) and (cid:2) Have Similar Activities in Multiple Endothelial Cell Pathways

  2002cites this paper
• The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives

  2002cites this paper
• Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways.

  2002cites this paper
• The many faces of transforming growth factor-beta in pleural diseases.

  2001cites this paper
• Microsatellite Mutation of Type II Transforming Growth Factor-&bgr; Receptor Is Rare in Atherosclerotic Plaques

  2001cites this paper
• Inhibition of Transforming Growth Factor- Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice

  2001cites this paper
• TGF-β and Related Cytokines in Inflammation

  2001cites this paper
• Suppressing thrombin generation is compatible with the development of atherosclerosis in mice.

  2001cites this paper
• Effect of estrogen on development of atherosclerosis. A review of experimental animal studies.

  2001cites this paper
• A Common Phenotype Associated with Atherogenesis in Diverse Mouse Models of Vascular Lipid Lesions

  2001cites this paper
• TGF-β and the cardiovascular system

  2001cites this paper
• Inhibition of Transforming Growth Factor-&bgr; Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice

  2001cites this paper
• Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen α1(I) and TIMP-1

  2001cites this paper
• The many faces of transforming growth factor- in pleural diseases

  2001cites this paper
• Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.

  2001cites this paper
• Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.

  2001cites this paper
• Formation of a functional morphogen gradient by a passive process in tissue from the early Xenopus embryo.

  2001cites this paper
• Raloxifene and estrogen inhibit neointimal thickening after balloon injury in the carotid artery of male and ovariectomized female rats.

  2000cites this paper
• Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese.

  2000cites this paper